# Sildenafil

## Revatio 20mg

##### 臨採

| TAH Drug Code      | [OREV](https://www.tahsda.org.tw/drugs/hissearch.php?drug_code=OREV)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                   |
|:-------------------|:---------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------|
| Indications        | Pulmonary arterial hypertension (PAH)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                  |
| Dosing             | Pulmonary arterial hypertension 20 mg TID; give doses approximately 4 to 6 hours apart. (maximum: 60mg/day)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                            |
| Hepatic Impairment | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Renal Impairment   | Dose adjustment not necessary                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                          |
| Contraindications  | Hypersensitivity to sildenafil or any component of the formulation; concurrent use (regularly/intermittently) of organic nitrates in any form (eg, nitroglycerin, isosorbide dinitrate); concomitant use of riociguat (a guanylate cyclase stimulator).                                                                                                                                                                                                                                                                                                                                                                                |
| Adverse Effects    | >10%: Flushing (10% to 19%), Headache (16% to 46%), Dyspepsia (3% to 17%; dose-related), Visual disturbance (2% to 11%; including vision color changes, blurred vision, and photophobia; dose-related), Epistaxis (9% to 13%) 2% to 10%: Insomnia (7%), dizziness (2% to 4%), paresthesia (3%), Erythema (6%), skin rash (1% to 3%), Diarrhea (3% to 9%), gastritis (?3%), nausea (2% to 3%), Urinary tract infection (3%), Increased liver enzymes (2% to 10%), Myalgia (2% to 7%), back pain (3% to 4%), Nasal congestion (4% to 9%), exacerbation of dyspnea (7%), nasal congestion (4%), rhinitis (4%), sinusitis (3%), Fever (6%) |
| Pregnancy          | No (Limited) Human Data – Animal Data Suggest Low Risk                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                 |
| Lactation          | No (Limited) Human Data - Potential Toxicity                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                           |
| More Info          | [UpToDate](https://www.uptodate.com/contents/sildenafil-drug-information)                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                                              |

